10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
3:19 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form RW | |
10/09/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
10/09/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
10/01/2024
7:00 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:31 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/01/2024
3:36 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
|
09/18/2024
4:38 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:32 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
7:45 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
| Form SC 13D/A | |
08/08/2024
3:26 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/06/2024
7:00 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
6:57 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:59 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:03 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:05 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:05 PM | CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:24 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 424B3 | |
05/28/2024
4:20 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:20 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:09 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEFA14A | |
04/11/2024
3:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form ARS | |
04/01/2024
5:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
5:21 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
03/21/2024
4:02 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
03/21/2024
4:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/02/2024
3:32 PM | BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
01/31/2024
11:11 AM | Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D | |
01/24/2024
6:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:55 PM | Avidity Partners Management LLC (0001993910) (Reporting)
Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Gregory Michael David (Reporting)
Meng Lei (Reporting)
Witzke David Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
4:26 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
01/22/2024
6:34 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:02 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
11/13/2023
8:02 AM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
